KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scansource (SCSC) Cash & Equivalents (2016 - 2025)

Scansource's Cash & Equivalents history spans 17 years, with the latest figure at $124.9 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 13.87% year-over-year to $124.9 million; the TTM value through Sep 2025 reached $124.9 million, down 13.87%, while the annual FY2025 figure was $126.2 million, 31.98% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $124.9 million at Scansource, down from $126.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $185.5 million in Q2 2024 and bottomed at $34.1 million in Q4 2021.
  • The 5-year median for Cash & Equivalents is $59.1 million (2021), against an average of $83.3 million.
  • The largest annual shift saw Cash & Equivalents tumbled 39.43% in 2022 before it surged 412.63% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $34.1 million in 2021, then skyrocketed by 94.72% to $66.4 million in 2022, then tumbled by 32.29% to $45.0 million in 2023, then surged by 145.67% to $110.5 million in 2024, then grew by 13.03% to $124.9 million in 2025.
  • Per Business Quant, the three most recent readings for SCSC's Cash & Equivalents are $124.9 million (Q3 2025), $126.2 million (Q2 2025), and $146.3 million (Q1 2025).